Covariates of corticotropin-releasing hormone (CRH) concentrations in cerebrospinal fluid (CSF) from healthy humans

BMC Neuroscience

Volumn 5, Issue , 2004, Pages

  Baraniuk, James N ^a   Maibach, Hilda ^a   Whalen, Gail ^a   Clauw, Daniel J ^b  

^a GEORGETOWN UNIVERSITY   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CATECHOLAMINE; CORTICOTROPIN RELEASING FACTOR; GLUCOSE; SODIUM; NEUROPEPTIDE Y;

ADULT; ARTICLE; CEREBROSPINAL FLUID ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; GLUCOSE BLOOD LEVEL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; LINEAR REGRESSION ANALYSIS; MALE; NORMAL HUMAN; RADIOIMMUNOASSAY; SODIUM BLOOD LEVEL; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; BLOOD; BREATHING; CEREBROSPINAL FLUID; COMPARATIVE STUDY; DEMOGRAPHY; FATIGUE; HEART RATE; METABOLISM; METHODOLOGY; PAIN; PHYSIOLOGICAL STRESS; PHYSIOLOGY; REGRESSION ANALYSIS; SEX DIFFERENCE; STATISTICAL MODEL; STATISTICS;

ADULT; BLOOD GLUCOSE; CONFIDENCE INTERVALS; CORTICOTROPIN-RELEASING HORMONE; DEMOGRAPHY; FATIGUE; FEMALE; HEART RATE; HUMANS; MALE; MODELS, STATISTICAL; NEUROPEPTIDE Y; PAIN; RADIOIMMUNOASSAY; REGRESSION ANALYSIS; RESPIRATION; SEX FACTORS; SODIUM; STATISTICS AS TOPIC; STRESS, PHYSIOLOGICAL;

EID: 12944294342     PISSN: 14712202     EISSN: None     Source Type: Journal    
DOI: 10.1186/1471-2202-5-58     Document Type: Article

References (37)

1. Bakshi VP, Kalin NH: Animal models and endophenotypes of anxiety and stress disorders:. In: Neuropsychopharmacology: 5th Generation of Progress Edited by: David KL, Charney D, Coyle JT, Nemeroff C. Lippincott Williams & Wilkins, New York; 2002:883-900.
2. Campbell RE, Grove KL, Smith MS: Distribution of corticotropin releasing hormone receptor immunoreactivity in the rat hypothalamus: coexpression in neuropeptide Y and dopamine neurons in the arcuate nucleus.Brain Res 2003, 973:223-32.
3. Lin Q, Zou X, Ren Y, Wang J, Fang L, Willis WD: Involvement of peripheral neuropeptide Y receptors in sympathetic modulation of acute cutaneous flare induced by intradermal capsaicin. Neuroscience 2004, 123:337-347.
4. Gracely RH, Geisser ME, Geisecke T, Grant MA, Petzke F, Williams DA, Clauw DJ: Pain castastrophizing and neural responses to pain among persons with fibromyalgia. Brain 2004, 127: 35-843. Epub 20004 Feb 11
5. Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL, Tugwell P, Campbell SM, Abeles M, Clark P: The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum 1990, 33:160-172.
6. Fukuda K, Straus SE, Hickie I, Sharpe MC, Dobbins JG, Komaroff A: The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group. Ann Intern Med 1994, 121:953-959.
7. Fukuda K, Nisenbaum R, Stewart G, Thompson WT, Robin L, Washko RM: Chronic mutlisymptom illness affecting air force veterans of the gulf war. JAMA 1999, 280:981-988.
8. Petrie A, Sabine C: Medical Statistics at a Glance. Oxford. Blackwell Science; 2000:75-77.
9. + -D-glucose cotransport systems. J Membr Biol 1994, 138:1-11.
10. Fulton S, Richard D, Woodside B, Shizgal P: Interaction of CRH and energy balance in the modulation of brain stimulation reward. Behav Neurosci 2002, 116:651-659.
11. Pelleymounter MA, Joppa M, Ling N, Foster AC: Pharmacological evidence supporting a role for central corticotropin-releasing factor(2) receptors in behavioral, but not endocrine, response to environmental stress. J Pharmacol Exp Therap 2002, 302:145-152.
12. Hand GA, Hewitt CB, Fulk LJ, Stock HS, Carson JA, Davis JM, Wilson MA: Differential release of corticotropin-releasing hormone (CRH) in the amygdala during different types of stressors. Brain Res 2002, 949:122-130.
13. Makino S, Hashimoto K, Gold PW: Multiple feedback mechanisms activating corticotropin-releasing hormone system in the brain during stress. Pharmacol Biochem Behav 2002, 73:147-158.
14. Swiergiel AH: Effects of infusion of corticotropin-releasing factor antagonist into the locus coeruleus on freezing behavior and brain catecholamines in rats. Acta Neurobiol Exp (Warsz) 2003, 63:9-16.
15. Bakshi VP, Smith-Roe S, Newman SM, Grigoriadis DE, Kalin NH: Reduction of stress-induced behavior by antagonism of corticotropin-releasing hormone 2 (CRH2) receptors in lateral septum or CRH1 receptors in amygdala. J Neurosci 2002, 22:2926-2935.
16. Pongratz G, Zietz B, Gluck T, Scholmerich J, Straub RH: Corticotropin-releasing factor modulates cardiovascular and pupillary autonomic reflexes in man: is there a link to inflammation-induced autonomic nervous hyperreflexia? Ann N Y Acad Sci 2002, 966: 73-383.
17. Dirks A, Groenink L, Bouwknecht JA, Hijzen TH, Van Der Gugten J, Ronken E, Verbeek JS, Veening JG, Dederen PJ, Korosi A, Schoolderman LF, Roubos EW, Olivier B: Overexpression of corticotropin-releasing hormone in transgenic mice and chronic stress-like autonomic and physiological alterations. Eur J Neurosci 2002, 16: 751-1760.
18. Strome EM, Wheler GH, Higley JD, Loriaux DL, Suomi SJ, Doudet DJ: Intracerebroventricular corticotropin-releasing factor increases limbic glucose metabolism and has social context-dependent behavioral effects in nonhuman primates. Proc Natl Acad Sci USA 2002, 99:15749-15754.
19. Nelson-Gray RO: DSM-IV: empirical guidelines from psychometrics. J Abnorm Psychol 1991, 100:308-315.
20. First MB, Spitzer RL, Gibbon M, Williams JBW: Structured clinical interview for DSM-IV Axis I disorders-patient edition (SCID-I/P, Version 2.0). New York: Biometrics Research Department, New York State Psychiatric Institute; 1996.
21. Rosenman SJ, Korten AE, Levings CT: Computerised diagnosis in acute psychiatry: validity of CIDI-Auto against routine clinical diagnosis. J Psychiatr Res 1997, 31:581-592.
22. Thornton C, Russell J, Hudson J: Does the Composite International Diagnostic Interview underdiagnose the eating disorders? Int J Eat Disord 1998, 23:341-345.
23. Cherpitel CJ: Analysis of cut points for screening instruments for alcohol problems in the emergency room. J Stud Alcohol 1995, 56:695-700.
24. Ware JE, Kosinski M, Keller SD: Physical and mental health summary scales: a user's manual. Boston: The Health Institute; 1994.
25. Ware JE, Sherbourne CD: The MOS 36-item short-form health survey (SF-36): I. Conceptual framework and item selection. Med Care1995, 30:473-483.
26. Lorig K, Chastain RL, Ung E, Shoor S, Holman HR: Development and evaluation of a scale to measure perceived self-efficacy in people with arthritis. Arthritis Rheum 1989, 32:37-44.
27. Weir R, Browne G, Roberts J, Tunks E, Gafni A: The Meaning of Illness Questionnaire: further evidence for its reliability and validity. Pain 1994, 58:377-386.
28. Smets EM, Garssen B, Bonke B, De Haes JC: The Multidimensional Fatigue Inventory (MFI) psychometric qualities of an instrument to assess fatigue. J Psychosom Res 1995, 39: 15-325.
29. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology: Heart rate variablility Standards of measurement, physiological interpretation and clinical use. Circulation 1996, 93:1043-1065.
30. Berntson GG, Bigger JT Jr, Eckberg DL, Grossman P, Kaufmann PG, Malik M, Nagaraja HN, Porges SW, Saul JP, Stone PH, van der Molen MW: Heart rate variability: origins, methods, and interpretive caveats. Psychophysiology 1997, 34:623-648.
31. Stein PK: Assessing heart rate variability from real-world Holter reports. Card Electrophysiol Rev 2002, 6:239-244.
32. Gracely RH, Lota L, Walter DJ, Dubner R: A multiple random staircase method of psychophysical pain assessment. Pain 1988, 32:55-63.
33. Gracely RH, Petzke F, Park K, Grant M, Clauw DJ: Functional MRI evidence of augmented pain processing in fibromyalgia. Arthritis Rheum 2002, 46:1333-1343.
34. Amieva H, Letenneur L, Dartigues JF, Rouch-Leroyer I, Sourgen C, D'Alchee-Biree F, Dib M, Barberger-Gateau P, Orgogozo JM, Fabrigoule C: Annual rate and predictors of conversion to dementia in subjects presenting mild cognitive impairment criteria defined according to a population-based study. Dement Geriatr Cogn Disord 2004, 18: 7-93.
35. Khurana RK, Setty A: The value of the isometric hand-grip test - studies in various autonomic disorders. Clin Auton Res 1996, 6:211-218.
36. Baraniuk JN, Castellino S, Goff J, Lundgren JD, Mullol J, Merida M, Shelhamer JH, Kaliner MA: Neuropeptide Y (NPY) in human nasal mucosa. Am J Respir Cell Mol Biol 1990, 3:165-173.
37. Liu Z, Welin M, Bragee B, Nyberg F: A high-recovery extraction procedure for quantitative analysis of substance P and opioid peptides in human cerebrospinal fluid. Peptides 2000, 21: 53-860.